Ixchelsis Ltd.

AnaBios Brings In $10m Series B Round, Including $4.2m From Principia AnaBios Corp. (focused on pain and cardiovascular and neurodegenerative diseases) closed a $10m Series B round, which included

It’s the 10th anniversary of START-UP ’s A-List. Since we began counting and sorting Series A rounds, then highlighting the most intriguing ones, we’ve never seen a year quite like 2013. On the publi

The U.K.’s Crescendo Biologics Ltd. has raised £17.5 million ($28 million) in a Series A financing in order to pursue development of its variable heavy-chain antibody fragments as therapeutics, a

Eli Lilly & Co. ’s venture investment experiment is beginning to bear fruit. The company has partnered with two health care investment firms, which have raised $250 million to put into single molecul